Douglas Slain

Summary

Affiliation: West Virginia University
Country: USA

Publications

  1. ncbi Infrequent occurrence of amphotericin B lipid complex-associated nephrotoxicity in various clinical settings at a university hospital: a retrospective study
    Douglas Slain
    School of Pharmacy, School of Medicine, West Virginia University, Morgantown 26506 9520, USA
    Clin Ther 24:1636-42. 2002
  2. ncbi Effect of high-dose vitamin C on the steady-state pharmacokinetics of the protease inhibitor indinavir in healthy volunteers
    Douglas Slain
    School of Pharmacy, West Virginia University, Morgantown, West Virginia 26506 9520, USA
    Pharmacotherapy 25:165-70. 2005
  3. ncbi Discrepancies between home medications listed at hospital admission and reported medical conditions
    Douglas Slain
    Department of Clinical Pharmacy, West Virginia University School of Pharmacy, Morgantown, West Virginia 26506 9520, USA
    Am J Geriatr Pharmacother 6:161-6. 2008
  4. ncbi Evaluation of an alternative posaconazole prophylaxis regimen in haematological malignancy patients receiving concomitant stress ulcer prophylaxis
    Ashley L Ross
    Department of Pharmacy Services, West Virginia University Healthcare, Morgantown, WV, USA
    Int J Antimicrob Agents 40:557-61. 2012
  5. ncbi Vancomycin administration during dialysis with low-flux polysulfone membranes: traditional versus a supplemental dosage regimen
    Mary K Stamatakis
    Department of Clinical Pharmacy, School of Pharmacy, West Virginia University, 1124 Health Sciences North, P.O. Box 9520, Morgantown, WV 26506-9520, USA
    Am J Health Syst Pharm 60:1564-8. 2003
  6. ncbi Assessment of a safety enhancement to the hospital medication reconciliation process for elderly patients
    Lucy A Gizzi
    Department of Pharmaceutical Services, West Virginia University Hospitals, Morgantown, West Virginia, USA
    Am J Geriatr Pharmacother 8:127-35. 2010
  7. ncbi Candida endophthalmitis: focus on current and future antifungal treatment options
    Fida A Khan
    Section of Infectious Diseases, Ohio Valley Medical Center, Wheeling, West Virginia, USA
    Pharmacotherapy 27:1711-21. 2007

Collaborators

  • Fida A Khan
  • Ashley L Ross
  • Lucy A Gizzi
  • Mary K Stamatakis
  • Michael Craig
  • Mehdi Hamadani
  • Alexander M Bryant
  • Aaron Cumpston
  • Frank Briggs
  • Renee Sager
  • Justin T Hare
  • Carl H Palmer
  • Erdogan Gunel
  • Joy M Schreiber

Detail Information

Publications7

  1. ncbi Infrequent occurrence of amphotericin B lipid complex-associated nephrotoxicity in various clinical settings at a university hospital: a retrospective study
    Douglas Slain
    School of Pharmacy, School of Medicine, West Virginia University, Morgantown 26506 9520, USA
    Clin Ther 24:1636-42. 2002
    ..3%). However, enrollment in that study was limited to only febrile neutropenic patients...
  2. ncbi Effect of high-dose vitamin C on the steady-state pharmacokinetics of the protease inhibitor indinavir in healthy volunteers
    Douglas Slain
    School of Pharmacy, West Virginia University, Morgantown, West Virginia 26506 9520, USA
    Pharmacotherapy 25:165-70. 2005
    ..To determine whether daily high-dose vitamin C alters the steady-state pharmacokinetics of indinavir, a protease inhibitor indicated for treatment of the human immunodeficiency virus type 1...
  3. ncbi Discrepancies between home medications listed at hospital admission and reported medical conditions
    Douglas Slain
    Department of Clinical Pharmacy, West Virginia University School of Pharmacy, Morgantown, West Virginia 26506 9520, USA
    Am J Geriatr Pharmacother 6:161-6. 2008
    ..The use of medications without a clear reported indication is of particular concern and has been associated with inappropriate use and polypharmacy...
  4. ncbi Evaluation of an alternative posaconazole prophylaxis regimen in haematological malignancy patients receiving concomitant stress ulcer prophylaxis
    Ashley L Ross
    Department of Pharmacy Services, West Virginia University Healthcare, Morgantown, WV, USA
    Int J Antimicrob Agents 40:557-61. 2012
    ..8, 95% CI 1.22-55.16] was associated with PCZ target attainment. These results suggest that PCZ target attainment is similar with either PCZ regimen but that there may be less of an interaction with H2As compared with PPIs...
  5. ncbi Vancomycin administration during dialysis with low-flux polysulfone membranes: traditional versus a supplemental dosage regimen
    Mary K Stamatakis
    Department of Clinical Pharmacy, School of Pharmacy, West Virginia University, 1124 Health Sciences North, P.O. Box 9520, Morgantown, WV 26506-9520, USA
    Am J Health Syst Pharm 60:1564-8. 2003
  6. ncbi Assessment of a safety enhancement to the hospital medication reconciliation process for elderly patients
    Lucy A Gizzi
    Department of Pharmaceutical Services, West Virginia University Hospitals, Morgantown, West Virginia, USA
    Am J Geriatr Pharmacother 8:127-35. 2010
    ....
  7. ncbi Candida endophthalmitis: focus on current and future antifungal treatment options
    Fida A Khan
    Section of Infectious Diseases, Ohio Valley Medical Center, Wheeling, West Virginia, USA
    Pharmacotherapy 27:1711-21. 2007
    ....